JOHN K BAKEWELL
CIK 1183553 · SVP, Research & Development · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.42M
Companies
8
Total Filings
46
Lifetime Open-Market Net
$555.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TMCI | Director | 454,056 | $4.01 | $1.82M | $594.6K | 8 | 2026-05-19 |
| XTNT | Director | 914,116 | $0.43 | $389.0K | $0 | 9 | 2025-11-18 |
| STIM | Director | 114,352 | $1.87 | $213.8K | -$38.9K | 5 | 2023-05-26 |
| Corindus Vascular Robotics, Inc. (CVRS) Delisted | Director | 32,072 | — | — | $0 | 2 | 2018-03-06 |
| ENTELLUS MEDICAL INC (ENTL) Delisted | Director | 0 | — | — | $0 | 4 | 2018-03-01 |
| EXACT SCIENCES CORP (EXAS) Delisted | Chief Financial Officer | — | $104.91 | — | $0 | 1 | 2016-01-05 |
| LNTH | CFO and Treasurer | 0 | $102.64 | $0 | $0 | 3 | 2016-01-04 |
| ev3 Inc. (EVVV) Delisted | Director | 4,148 | — | — | $0 | 5 | 2010-07-13 |
Recent Filings · Page 3 of 5
46 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-07 | XTNT | Grant (A) | +116,197 | $0 | EDGAR |
| 2019-09-25 | XTNT | Grant (A) | +5,555 | $0 | EDGAR |
| 2018-04-10 | XTNT | Grant (A) | +26,042 | $0 | EDGAR |
| 2018-03-06 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | +32,072 | $0 | EDGAR |
| 2018-03-01 | ENTELLUS MEDICAL INC (ENTL) Delisted | Disp (D) | −2,500 | -$60.0K | EDGAR |
| 2017-12-19 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-14 | ENTELLUS MEDICAL INC (ENTL) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
| 2016-06-15 | ENTELLUS MEDICAL INC (ENTL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-05 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-04 | LNTH | Disp (D) | −83,500 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.